GartlehnerGGaynesBNHansenRA. Comparative benefits and harms of second-generation of antidepressants: background paper for the American College of Physicians. Ann Intern Med2008;149:734–50.
2.
NaranjoCABustoUSellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981;30:239–45.
3.
AnttilaSALeinonenEV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev2001;7:249–64.
4.
CheahCYLadhamsBFeganPG. Mirtazapine associated with profound hyponatremia: two case reports. Am J Geriatr Pharmacother2008;6:91–5.
5.
SpinaESantoroVD'arrigoC. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther2008;30:1206–27.
